We aim to modernize the $1.4 B home gardening market by introducing grafted vegetable plants. Our competitive advantages are a team of plant physiologists/technologist, marketing/sales, and leadership experts, and our indoor controlled system that increases plant quality and production per unit area. We will penetrate the market through the $106 M niche of tomato transplants. The projected gross sales on year 5 are $ 9.6 M with 81% gross margin.